Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02739347 : Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia
AgesMin: 18 Years Max: 50 Years
Inclusion Criteria:

Early course psychosis:

- DSM-V diagnosis of Schizophrenia, Schizoaffective disorder, or schizophreniform

- ages 18-50 years

- within first five years of anti-psychotic treatment

- on stable doses of medication for at least one month

- not taking benzodiazepines or mood stabilizers.

- Mild to severe cognitive impairment in MATRICS Consensus Cognitive Battery (composite
scores < 40)

Chronic psychosis:

Same as early course psychosis but >5 years of antipsychotic treatment

Exclusion Criteria:

- Diagnostic and Statistical Manual-Version V (DSM-V) diagnosis of mental retardation

- significant head injury

- medical illness affecting brain function or structure

- pregnancy or postpartum (<6 weeks after delivery or miscarriage)

- significant neurologic disorder (e.g seizure disorder)

- inability to provide informed consent

- significant color blindness that affects task performance

- Comorbidity for DSM-V substance abuse disorder within the past one month

- Temporal relation between illness onset and head injury

- Taking benzodiazepines or mood stabilizers (lithium allowed)
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557